Stay updated on BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.

Latest updates to the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page
- Check7 days agoChange DetectedThe page now shows a new site revision label, Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates an update to the page framework or template that does not affect the study content or eligibility details.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedFooter revision label updated to v3.6.6, replacing the prior v3.6.5. This reflects a minor site maintenance update to the page metadata.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a newer version of the page. This appears to be a minor template/metadata change that does not modify study content or outcomes.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small update to the study record page. The change affects only metadata and does not modify the study content.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a page-level version update. This appears to be an internal maintenance change and does not alter study data or user-facing content.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page's revision label changed from v3.6.0 to v3.6.2, indicating a patch-level update to the page. No study data or instructions are altered by this change.SummaryDifference0.0%

Stay in the know with updates to BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.